This chapter content advances SDG 3 and 5 by explaining how diethylstilbestrol has been used in the past by obstetricians, gynecologists, and family physicians to treat pregnant women with the intent to prevent miscarriage, and the antimiscarriage use of this drug had side effects that became tragically clear soon after the commercialization showing the failure of adequate preclinical testing.